Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis

Fig. 2

Tumor response in different organs following treatment with lenvatinib plus anti-PD-1 antibodies. a–e Change from baseline in tumor size according to INV assessment; f–j change from baseline in tumor size according to IIR assessment. Each bar represents one patient. MVTT, macrovascular tumor thrombi

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us